Envestnet Asset Management Inc Theravance Biopharma, Inc. Transaction History

Envestnet Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$22.83 - $32.67 $15,455 - $22,117	-677 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$22.06 - $25.52 $1,676 - $1,939	76 Added 12.65%	677 $15,000
Q1 2018 May 09, 2018	BUY	$23.37 - $29.71 $6,496 - $8,259	278 Added 86.07%	601 $15,000
Q4 2017 Feb 20, 2018	BUY	$25.82 - $35.66 $671 - $927	26 Added 8.75%	323 $9,000
Q3 2017 Nov 13, 2017	BUY	$23.88 - $34.96 $2,483 - $3,635	104 Added 53.89%	297 $10,000
Q2 2017 Aug 14, 2017	BUY	N/A	193	193 $8,000

122

47.3M

200

12.8K

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $640M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.